Riskpilot← Back to searchSign inGet full accessDiagnostico Sverige AB
ABActiveOrg 5590780390Sveavägen 60 5trHospital activities · NACE 8610Est. 20160 employees
Revenue 2024
SEK 0
EBITDA margin
—
-15% vs 2023
Equity ratio
97.2%
Financial strength
Net profit 2024
SEK -72K
-15% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -72K | -15% |
| Net profit | SEK -72K | -15% |
| Total assets | SEK 507K | +1% |
| Equity | SEK 493K | +6% |
| Employees | 0 | — |
Legal name
Diagnostico Sverige AB
Org number
5590780390
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
28 september 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska utföra och sälja diagnostiska hälsovårdstester för privatpersoner samt erbjuda relaterade tjänster och produkter. Verksamheten ska också inkludera därmed förenlig verksamhet.
Address
Sveavägen 60 5tr
Email
patrikhansson1@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 682 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 244 | −128 | −32 | −63 | −72 |
| Depreciation & amort. | −19 | −19 | −19 | — | — |
| EBIT | 225 | −147 | −51 | −63 | −72 |
| Net financials | — | — | — | — | −0 |
| Profit before tax | 169 | −3 | −51 | −63 | −72 |
| Tax | −36 | −0 | — | — | — |
| Net profit | 133 | −3 | −51 | −63 | −72 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 319 | 259 | 208 | 500 | 507 |
| Equity | 262 | 259 | 208 | 465 | 493 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 1 | 0 | — | 35 | 14 |
| Total debt | 1 | — | — | 35 | 14 |
EBITDA margin
-7217400.0%
This company
15.8%
Market median
-45679847% vs market
20202024
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20202024
Return on equity
-14.7%
This company
18.4%
Market median
-180% vs market
20202024
Net profit margin
-7249900.0%
This company
8.1%
Market median
-89505038% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BH | Audit | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2023 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Diagnostico Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Harald Merseburg | Audit | 0 companies |
| Rune Patrik Fabian Hansson | Chairman | 0 companies |
| Eva Susanne Lyrberg | Deputy Board Member | 0 companies |
| Carl Christofer Grimås | Board of Directors | 0 companies |
| Carl Johannes Grimås | Deputy Board Member | 0 companies |